These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27130715)

  • 1. Cases of acquired C1 inhibitor deficiency treated with rituximab.
    Doshi A; Tse K; Riedl M; Zuraw B; Christiansen S
    J Allergy Clin Immunol Pract; 2016; 4(5):987-8. PubMed ID: 27130715
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and biological response to rituximab treatment in 3 patients with acquired C1-inhibitor deficiency.
    Busse PJ; Gernez Y
    Ann Allergy Asthma Immunol; 2017 Oct; 119(4):380-382. PubMed ID: 28866304
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinin formation in C1 inhibitor deficiency.
    Kaplan AP; Joseph K
    J Allergy Clin Immunol; 2010 Jun; 125(6):1411-2; author reply 1412. PubMed ID: 20381848
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.
    Farkas H; Reshef A; Aberer W; Caballero T; McCarthy L; Hao J; Nothaft W; Schranz J; Bernstein JA; Li HH
    J Allergy Clin Immunol Pract; 2017; 5(6):1671-1678.e2. PubMed ID: 28601641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic agents for hereditary angioedema.
    Giavina-Bianchi P; Motta A; Kalil J
    N Engl J Med; 2011 Jan; 364(1):85; author reply 86. PubMed ID: 21208116
    [No Abstract]   [Full Text] [Related]  

  • 6. Real-life experience with long-term prophylactic C1 inhibitor concentrate treatment of patients with hereditary angioedema: Effectiveness and cost.
    Rasmussen ER; Aagaard L; Bygum A
    Ann Allergy Asthma Immunol; 2016 May; 116(5):476-7. PubMed ID: 27017563
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary angioedema--therapies old and new.
    Morgan BP
    N Engl J Med; 2010 Aug; 363(6):581-3. PubMed ID: 20818894
    [No Abstract]   [Full Text] [Related]  

  • 8. Bradykinin-mediated diseases.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of acquired C1 inhibitor deficiency with icatibant.
    Bright P; Dempster J; Longhurst H
    Clin Exp Dermatol; 2010 Jul; 35(5):553-4. PubMed ID: 20337653
    [No Abstract]   [Full Text] [Related]  

  • 10. Icatibant.
    Dubois EA; Cohen AF
    Br J Clin Pharmacol; 2010 May; 69(5):425-6. PubMed ID: 20573077
    [No Abstract]   [Full Text] [Related]  

  • 11. Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.
    Firinu D; Barca MP; Serusi L; Lorrai MM; Peralta MM; Manconi PE; Del Giacco SR
    Int J Immunopathol Pharmacol; 2012; 25(1):269-73. PubMed ID: 22507340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of C1 inhibitor concentrate in hereditary angioedema with C1 inhibitor deficiency: Analysis in a French cohort.
    Belbézier A; Boccon-Gibod I; Thanh AD; Fain O; Bouillet L;
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):506-508. PubMed ID: 29964227
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hereditary angioedema].
    Bouchard LJ; Hyry H; Meri S
    Duodecim; 2012; 128(24):2547-54. PubMed ID: 23393928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icatibant Exposure During Pregnancy in a Patient With Hereditary Angioedema.
    Zanichelli A; Mansi M; Periti G
    J Investig Allergol Clin Immunol; 2015; 25(6):447-9. PubMed ID: 26817146
    [No Abstract]   [Full Text] [Related]  

  • 15. [Allergy-immunology. New therapies for acute attacks in hereditary angioedema].
    Leimgruber A
    Rev Med Suisse; 2011 Jan; 7(278):103-5. PubMed ID: 21400938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week.
    Bork K; Hardt J
    Int Arch Allergy Immunol; 2011; 154(1):81-8. PubMed ID: 20664282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icatibant for the treatment of hereditary angioedema.
    Cole SW; Lundquist LM
    Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective study.
    Javaud N; Gompel A; Bouillet L; Boccon-Gibod I; Cantin D; Smaiti N; Carpentier F; Boubaya M; Launay D; Adnet F; Fain O
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):499-503. PubMed ID: 25935434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired C1-inhibitor deficiency presenting with nephrotic syndrome.
    Willows J; Wood K; Bourne H; Sayer JA
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31300605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hereditary angioedema: a review (CME).
    Bhardwaj N; Craig TJ
    Transfusion; 2014 Nov; 54(11):2989-96; quiz 2988. PubMed ID: 24735226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.